Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options

Published:2018-10-29 Issue:11 Volume:16 Page:833-838
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Loggi Elisabetta¹,Vukotic Ranka¹,Andreone Pietro¹

Affiliation:

1. Dipartimento di Scienze Mediche e Chirurgiche, Centro Studi e Ricerca sulle Epatiti, Università di Bologna, Bologna, Italy

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2018.1538783

Reference42 articles.

1. Global epidemiology and burden of HCV infection and HCV-related disease

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

3. Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens

4. HCV variability, the immune system and resistance to antiviral drugs

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti HCV activity and expression inhibition of HCC markers by protein extract from Iberis gibraltarica;Brazilian Journal of Biology;2024

2. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP